<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.healthnewspapers.com/womens-health/maternal-haemoglobin-thresholds-preterm-birth-altitude</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-04</news:publication_date>
      <news:title>Both low and high haemoglobin in pregnancy tracked with preterm birth, by gestational week</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/unicorn-botensilimab-balstilimab-neoadjuvant-colon-cancer</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-04</news:publication_date>
      <news:title>Immunotherapy before surgery cleared tumours in a 56-patient colon cancer trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/sirva-covid-versus-influenza-vaccination-cohort</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-04</news:publication_date>
      <news:title>Shoulder injury after vaccination is rare, slightly likelier after COVID than flu shots</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/helios-b-vutrisiran-attr-cardiomyopathy-open-label-extension</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-04</news:publication_date>
      <news:title>Vutrisiran&apos;s benefit in a heart amyloidosis trial held through four years</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/policy/fda-transfusion-transmitted-hepatitis-b-guidance</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-04</news:publication_date>
      <news:title>FDA drops a hepatitis B blood test where two others are run</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/policy/fda-cgt-potency-assurance-guidance</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-04</news:publication_date>
      <news:title>FDA finalises potency-assurance guidance for cell and gene therapies</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/policy/cms-opo-conditions-for-coverage-final-rule</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-04</news:publication_date>
      <news:title>CMS finalises organ-procurement rules, clarifying competition and appeals for OPOs</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/global-health/shamonda-virus-first-human-case-france</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-04</news:publication_date>
      <news:title>First human infection with Shamonda virus confirmed in France after fatal encephalitis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/lucamzi-ranibizumab-biosimilar-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-04</news:publication_date>
      <news:title>FDA approves Lucamzi, a ranibizumab biosimilar to Lucentis, for three eye conditions</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/ilumya-tildrakizumab-active-psoriatic-arthritis</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-04</news:publication_date>
      <news:title>FDA clears Ilumya for active psoriatic arthritis, its second indication</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/gout-lower-limb-amputation-type-2-diabetes</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-04</news:publication_date>
      <news:title>Gout is linked to higher amputation risk in type 2 diabetes</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/ectopic-cushing-syndrome-international-cohort</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-04</news:publication_date>
      <news:title>The largest study of ectopic Cushing syndrome maps who dies, and why</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/bilag-br-ethnicity-lupus-treatment-response</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-04</news:publication_date>
      <news:title>Black patients responded least to escalated lupus treatment in a UK register</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/awiqli-insulin-icodec-paediatric-type-2-diabetes</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-04</news:publication_date>
      <news:title>Awiqli weekly insulin extended to children aged 10 and older with type 2 diabetes</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/1care-smartphone-treat-to-target-gout-trial</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-04</news:publication_date>
      <news:title>A smartphone-run gout programme hit urate targets in most patients</news:title>
    </news:news>
  </url>
</urlset>